Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: Natural history of relapse after initial complete response and prognostic variables defining outcome after relapse
Open Access
- 1 November 1997
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 8 (11), 1125-1132
- https://doi.org/10.1023/a:1008263602334
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphomaBlood, 1992
- Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphoma with MACOP-B: a Southwest Oncology Group study.Journal of Clinical Oncology, 1991
- Late relapse with nodular lymphoma after treatment for diffuse non-Hodgkin's lymphomaCancer, 1991
- Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.Journal of Clinical Oncology, 1991
- The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen.Journal of Clinical Oncology, 1990
- High-grade non-Hodgkin lymphoma relapsing as low-grade follicular lymphoma: So-called downgraded lymphomaAmerican Journal of Hematology, 1989
- Downgrading of Non-Hodgkin’s Lymphoma following ChemotherapyActa Haematologica, 1987
- Relapse with Nodular Lymphoma Following Combination Chemotherapy for Diffuse Non-Hodgkinʼs LymphomaAmerican Journal of Clinical Oncology, 1986
- National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usageCancer, 1982